16 Nov
2020

Indian court casts critical eye on “strawman” patent opposition

A recent case involving Pfizer shows that both appeal board and courts are concerned that delays to patent grant can be compounded by abuse of the opposition process.

Jacob Schindler

Author | Asia-Pacific editor

[email protected]

Jacob Schindler